Loading clinical trials...

Radioembolization Versus External Radiation Therapy | Clinical Trials | Clareo Health

RECRUITINGPhase 2NCT07530172

Radioembolization Versus External Radiation Therapy

The proposed study is a single site, prospective, randomized phase 2 study to evaluate the efficacy and tolerability transarterial radioembolization (TARE) versus stereotactic body radiation therapy (...

Lead sponsor: Henry Ford Health System•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Marissa Gilbert

CONTACT

313-556-8422 mgilber6@hfhs.org

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment146

Start dateDec 2025

Last updatedApr 15, 2026

Condition

Heptocellular Cancer

Locations shown

Henry Ford Health System

Detroit, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions